ALKYL (S)-1-((S)-2-{5-4-(4-{2-(S)-1-((S)-2-METHOXYCARBONYLAMINO-3-METHYL-BUTYRYL)PYRROLIDINE-2-YL-3H-IMIDAZOLE-4-YL}BUTA-1,3-DIENYL)PHENYL-1H-IMIDAZOLE-2-YL}PYRROLIDINE-1-CARBONYL)-2-METHYL-PROPYLCARBAMATE NAPHTHALENE-1,5-DISULFONATE, PHARMACEUTICAL COMPOSITION, MEDICINAL AGENT AND METHOD FOR TREATMENT OF VIRAL DISEASES

摘要

The present invention relates to NS5A inhibitors, to a novel pharmaceutical composition, to an antiviral medicinal agent, and to a method for the prevention and treatment of viral diseases, particularly those caused by the hepatitis C (HCV) and hepatitis GBV-C viruses. Proposed are alkyl [(S)-1-((S)-2-{5-[4-(4-{2-[(S)-1-((S)-2-methoxycarbonylamino-3-methyl-butyryl)pyrrolidine-2-yl]-3H-imidazole-4-yl}buta-1,3-dienyl)phenyl]-1H-imidazole-2-yl}pyrrolidine-1-carbonyl)-2-methyl-propyl]carbamate naphthalene-1,5-disulfonate of general formula 1, optionally in crystalline or polycrystalline form:; ;where R is C₁-C₃ alkyl.